E. Canby-Hagino

发表

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

E. Messing, J. Chin, I. Thompson, 2009, The Journal of urology.

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

E. Messing, J. Chin, I. Thompson, 2006, JAMA.

Guideline for the management of clinically localized prostate cancer: 2007 update.

A. D'Amico, C. Tangen, D. Eton, 2007, The Journal of urology.

UPDATE OF SWOG 8794: ADJUVANT RADIOTHERAPY FOR PT3 PROSTATE CANCER IMPROVES METASTASIS FREE SURVIVAL

J. Chin, I. Thompson, C. Tangen, 2008 .

Retracted: Many young men with prostate‐specific antigen (PSA) screen‐detected prostate cancers may be candidates for active surveillance

John W. Davis, E. Canby-Hagino, Jeri Kim, 2013, BJU international.

Increasing rates of low-risk prostate cancer incidence in USAF servicemen and selection of treatments

E. Canby-Hagino, D. J. Junco, E. Fox, 2011 .

Chemoprevention of prostate cancer.

I. Thompson, E. Canby-Hagino, O. Brawley, 1994, Urology.

Anemia in men with advanced prostate cancer: incidence, etiology, and treatment.

E. Canby-Hagino, Jeffrey G Nalesnik, A. Mysliwiec, 2004, Reviews in urology.

THE EFFICACY OF 11 CARBON ACETATE PET SCAN IN THE STAGING AND MANAGEMENT OF PROSTATE CANCER

E. Canby-Hagino, J. Arenas, 2009 .

Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention.

E. Canby-Hagino, I. Thompson, T. Brand, 2007, European urology.

Chemoprevention of prostate cancer with finasteride

I. Thompson, E. Canby-Hagino, T. Brand, 2006, Expert opinion on pharmacotherapy.

Intraluminal pneumatic lithotripsy for the removal of encrusted urinary catheters.

E. Canby-Hagino, R. D. Caballero, W. Harmon, 1999, The Journal of urology.

Coccidioidomycosis of the epididymis and testis.

E. Canby-Hagino, T. Dykes, A. B. Stone, 2005, AJR. American journal of roentgenology.

Radiologic-Pathologic Conference of Wilford Hall Medical Center Coccidioidomycosis of the Epididymis and Testis

E. Canby-Hagino, T. Dykes, A. B. Stone, 2005 .

Evolution of Prostate-Specific Antigen for Screening

E. Canby-Hagino, J. Hernández, 2009 .

Prostate cancer detection strategies

I. Thompson, E. Canby-Hagino, T. Brand, 2006 .

Biomarkers for the detection and prognosis of prostate cancer

I. Thompson, E. Canby-Hagino, J. Hernández, 2005, Current urology reports.

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.

Javier Hernandez, Timothy Brand, Robin J Leach, 2006, Urology.

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.

Anthony V D'Amico, Javier Hernandez, Arthur L Burnett, 2007, The Journal of urology.

Fibrin sealant treatment of splenic injury during open and laparoscopic left radical nephrectomy.

J. Bishoff, I. Jatoi, E. Canby-Hagino, 2000, The Journal of urology.

I. Thompson, C. Moinpour, E. Canby-Hagino, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

E. Messing, J. Chin, I. Thompson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Testosterone replacement therapy and prostate cancer: A word of caution

I. Thompson, E. Canby-Hagino, T. Brand, 2008 .

Testosterone replacement therapy and prostate cancer: A Word of Caution

I. Thompson, E. Canby-Hagino, T. Brand, 2007 .

Association of polymorphisms in TGFB1 and prostate cancer prognosis.

I. Thompson, S. Naylor, D. Troyer, 2008, The Journal of urology.

Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer

E. Messing, J. Chin, I. Thompson, 2007 .

Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk.

E. Canby-Hagino, A. Morey, J. Foley, 2002, The Journal of urology.

Stage migration and grade inflation in prostate cancer: Will Rogers meets Garrison Keillor.

I. Thompson, M. Lucia, E. Canby-Hagino, 2005, Journal of the National Cancer Institute.

Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.

I. Thompson, S. Naylor, D. Troyer, 2009, The Journal of urology.

1665: Adjuvant Radiotherapy for Pathologic T3 Prostate Cancer: Results of a Randomized, Prospective Clinical Trial with Metastasis-Free Survival Endpoint

E. Messing, J. Chin, I. Thompson, 2005 .

The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794.

E. Messing, J. Chin, I. Thompson, 2008, The Journal of urology.

Erectile function outcome reporting after clinically localized prostate cancer treatment.

Anthony V D'Amico, Javier Hernandez, S Larry Goldenberg, 2007, The Journal of urology.

Mechanisms of Disease: prostate cancer—a model for cancer chemoprevention in clinical practice

Ian M Thompson, I. Thompson, E. Canby-Hagino, 2005, Nature Clinical Practice Oncology.

Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?

I. Thompson, E. Crawford, G. Swanson, 2005 .

Screening for prostate cancer: opportunities and challenges.

I. Thompson, E. Canby-Hagino, C. Bermejo, 2005, Surgical oncology clinics of North America.

Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments.

E. Canby-Hagino, E. Fox, C. Pettaway, 2011, The Journal of urology.

Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.

I. Thompson, D. Ankerst, D. Parekh, 2007, Urology.

Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.

G. Haas, I. Thompson, C. Tangen, 2012, Urology.

Chemoprevention of prostate cancer.

I. Thompson, C. Coltman, E. Canby-Hagino, 2006, Hematology/oncology clinics of North America.

Prognostic features in men who died of prostate cancer.

D. Troyer, E. Canby-Hagino, J. Hernández, 2005, The Journal of urology.